Evidence map›Paper›PMID 33638312›Full record

ArticleInfluenza and other respiratory viruses2021

Comparison of performance between Fast Track Diagnostics Respiratory Kit and the CDC global reference laboratory for influenza rRT-PCR panel for detection of influenza A and influenza B.

Assana Cissé, Jennifer Milucky, Abdoul Kader Ilboudo, Jessica L Waller, Brice Bicaba, Isaïe Medah, Sara Mirza, Cynthia G Whitney, Zekiba Tarnagda

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Assana CisséLaboratoire National de Référence-Grippes (LNR-G), Institut de Recherche en Sciences de la Santé (IRSS), Bobo Dioulasso, Burkina Faso.
Jennifer MiluckyCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA.ORCID 0000-0002-1491-4669
Abdoul Kader IlboudoLaboratoire National de Référence-Grippes (LNR-G), Institut de Recherche en Sciences de la Santé (IRSS), Bobo Dioulasso, Burkina Faso.
Jessica L WallerCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA.
Brice BicabaDirection de la Protection de la Santé de la Population, Ministère de la Santé, Ouagadougou, Burkina Faso.
Isaïe MedahDirection de la Protection de la Santé de la Population, Ministère de la Santé, Ouagadougou, Burkina Faso.
Sara MirzaCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA.
Cynthia G WhitneyCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA.
Zekiba TarnagdaLaboratoire National de Référence-Grippes (LNR-G), Institut de Recherche en Sciences de la Santé (IRSS), Bobo Dioulasso, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReliable diagnostics are a key to identifying influenza infections.

objectivesOur objectives were to describe the detection of influenza among severe acute respiratory infection (SARI) cases, to compare test results from the Fast Track Diagnostics (FTD) Kit for influenza detection to the Centers for Disease Control (CDC) human influenza virus detection and characterization panel, and to assess seasonality of influenza in Burkina Faso.

methodsNasopharyngeal and oropharyngeal specimens from SARI cases (hospitalized patients with fever, cough, and onset in the previous 10 days) were tested using the FTD-33 Kit and the CDC rRT-PCR influenza assays. We assessed sensitivity and specificity of the FTD-33 Kit for detecting influenza A, influenza B, and the influenza A(H1N1)pdm09 strain using the CDC human influenza rRT-PCR panel as the gold standard.

resultsFrom December 2016 to February 2019, 1706 SARI cases were identified, 1511 specimens were tested, and 211 were positive for influenza A (14.0%) and 100 for influenza B (6.6%) by either assay. Higher influenza circulation occurred between November and April with varying peaks of influenza A and influenza B. Sensitivity of the FTD-33 assay was 91.9% for influenza A, 95.7% for influenza B, and 93.8% for A(H1N1)pdm09 subtype. Specificity was over 99% for all three tests.

conclusionsOur study indicates that Burkina Faso has one peak of influenza each year which is similar to the Northern Hemisphere and differs from other countries in West Africa. We found high concordance of influenza results between the two assays indicating FTD-33 can be used to reliably detect influenza among SARI cases.

Indexed as

Influenza A Virus, H1N1 SubtypeInfluenza, HumanCenters for Disease Control and Prevention, U.S.HumansLaboratoriesReverse Transcriptase Polymerase Chain ReactionUnited StatesBurkina Fasodiagnosticsinfluenzasevere acute respiratory infectionsWest Africa

Identifiers

PMID33638312
PMCPMC8051705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.